We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing ...

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

Biotechnology company Veracyte (VCYT) is set to replace Triumph Group (TGI) in the S&P SmallCap 600 index prior to the market open on Tuesday, July 29.

Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE: TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners ...

Defense and security solutions provider KRATOS DEFENSE AND SECURITY SOLUTIONS INC (NASDAQ: KTOS) saw a sell-off by ARK, with 36,628 shares sold between the ARKQ and ARKX (NYSE: ARKX) ETFs, valued at ...

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society, taking place July ...

Veracyte Inc. Annual cash flow by MarketWatch. View VCYT net cash flow, operating cash flow, operating expenses and cash dividends.

View the latest Veracyte Inc. (VCYT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Tempus AI TEM continues to push the boundaries of precision medicine through a robust pipeline of research and development (R&D) initiatives. In June, the company introduced xM, a liquid biopsy assay ...

Veracyte Inc. research and ratings by Barron's. View VCYT revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.